Metric: Brand drug prices surge ahead of inflation rate

Drug prices moderated somewhat over the past year, but brand-name prescription prices are still soaring far ahead of inflation, according to AARP. Their report on the wholesale prices of 200 brand name medications commonly used in the US shows a 6.1 percent price hike in the 12 months through June. That's down slightly from 7.1 percent a year ago. One bright spot: The prices of 75 generic drugs remained flat. PhRMA called the report flawed because it looks at wholesale rather than retail prices and doesn't take into account discounts offered on medications.

- read this report from USA Today for more

Suggested Articles

Out of options, Tocagen will become Forte Biosciences’ route to the public markets through an all-stock reverse merger.

Reich co-founded Effector and served as its SVP of research but has moved on to take up the CSO position at Turning Point Therapeutics.

BioMarin’s hemophilia A drug has been set an Aug. 21 PDUFA date as the California biotech looks to gain a speedy approval.